Literature DB >> 24398574

Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.

Dana M Chase1, Steven J Gibson, Daniele A Sumner, Jennifer W Bea, David S Alberts.   

Abstract

OPINION STATEMENT: Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

Entities:  

Mesh:

Year:  2014        PMID: 24398574     DOI: 10.1007/s11864-013-0269-x

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  37 in total

1.  Acupressure for postoperative nausea and vomiting in gynaecological patients receiving patient-controlled analgesia.

Authors:  S Turgut; G Ozalp; S Dikmen; S Savli; G Tuncel; N Kadiogullari
Journal:  Eur J Anaesthesiol       Date:  2006-08-08       Impact factor: 4.330

2.  Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy.

Authors:  Amber Klein; Xiaoying He; Maria Roche; Allison Mallett; Linda Duska; Jeffrey G Supko; Michael V Seiden
Journal:  Gynecol Oncol       Date:  2005-09-19       Impact factor: 5.482

3.  Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis.

Authors:  Kun Zhu; Ichio Fukasawa; Makiko Furuno; Fujiyuki Inaba; Tatsuo Yamazaki; Tetsu Kamemori; Nobuaki Kousaka; Yoriko Ota; Masatoshi Hayashi; Toshiyuki Maehama; Noriyuki Inaba
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

4.  The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring.

Authors:  K K L Chan; T J Yao; B Jones; J F Zhao; F K Ma; C Y Leung; S K Lau; M W Yip; H Y S Ngan
Journal:  Ann Oncol       Date:  2011-02-25       Impact factor: 32.976

5.  How women with advanced cancer pray: a report from two focus groups.

Authors:  Amy Rex Smith; Susan DeSanto-Madeya; John E Pérez; Elizabeth F Tracey; Susan DeCristofaro; Rebecca L Norris; Shruti L Mukkamala
Journal:  Oncol Nurs Forum       Date:  2012-05-01       Impact factor: 2.172

Review 6.  The use of antioxidant therapies during chemotherapy.

Authors:  Jeanne A Drisko; Julia Chapman; Verda J Hunter
Journal:  Gynecol Oncol       Date:  2003-03       Impact factor: 5.482

7.  A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.

Authors:  U Matulonis; S Campos; L Duska; A Fuller; R Berkowitz; S Gore; M Roche; T Colella; H Lee; M V Seiden
Journal:  Gynecol Oncol       Date:  2003-11       Impact factor: 5.482

8.  Remedies and life changes among invasive cervical cancer survivors.

Authors:  Howard P Greenwald; Ruth McCorkle
Journal:  Urol Nurs       Date:  2007-02

9.  L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.

Authors:  Ricardo A Cruciani; Jenny J Zhang; Judith Manola; David Cella; Bilal Ansari; Michael J Fisch
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

10.  The use of music to reduce anxiety for patients undergoing colposcopy: a randomized trial.

Authors:  Y M Chan; Peter W H Lee; T Y Ng; Hextan Y S Ngan; L C Wong
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

View more
  4 in total

1.  Complementary, Traditional and Spiritual Practices Used by Cancer Patients in Turkey When Coping with Pain: An Exploratory Case Study.

Authors:  Ezgi Karadag; Seda Yüksel
Journal:  J Relig Health       Date:  2021-05-14

2.  Prolonged stabilization of platinum-refractory ovarian cancer in a single patient undergoing long-term Mistletoe extract treatment: Case report.

Authors:  Woo Yeon Hwang; Mi Hyun Kang; Seul Ki Lee; Ji Su Yeom; Min Hyung Jung
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

3.  Acceptance and use of complementary and alternative medicine among medical specialists: a 15-year systematic review and data synthesis.

Authors:  Phanupong Phutrakool; Krit Pongpirul
Journal:  Syst Rev       Date:  2022-01-14

4.  An Integrated Study on the Antitumor Effect and Mechanism of Triphala Against Gynecological Cancers Based on Network Pharmacological Prediction and In Vitro Experimental Validation.

Authors:  Yuhang Zhao; Min Wang; Jokyab Tsering; Hanluo Li; Simin Li; Yuepeng Li; Yinghua Liu; Xianda Hu
Journal:  Integr Cancer Ther       Date:  2018-05-10       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.